4.1 Review

An update on the clinical and molecular characteristics of pseudohypoparathyroidism

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MED.0b013e32835a255c

Keywords

GNAS; hormone resistance; imprinting

Funding

  1. NIDDK NIH HHS [R01 DK079970] Funding Source: Medline

Ask authors/readers for more resources

Purpose of review To provide the reader with a review of contemporary literature describing the evolving understanding of the molecular pathobiology of pseudohypoparathyroidism (PHP). Recent findings The features of PHP type 1 reflect imprinting of the GNAS gene, which encodes the alpha subunit of the heterotrimeric G protein (G alpha(s)) that couples heptahelical receptors to activation of adenylyl cyclase. Transcription of G alpha(s) is biallelic in most cells, but is primarily from the maternal allele in some tissues (e.g. proximal renal tubules, thyroid, pituitary somatotropes, gonads). Patients with PHP 1a have heterozygous mutations within the exons of the maternal GNAS allele that encode G alpha(s), whereas patients with PHP 1b have methylation defects in the GNAS locus that reduce transcription of G alpha(s) from the maternal allele. In both PHP 1a and PHP 1b, paternal imprinting of G alpha(s) leads to resistance to parathyroid hormone and TSH. Although brachydactyly is characteristic of PHP 1a, it is sometimes present in patients with PHP 1b. Summary Molecular studies enable a distinction between PHP 1a and PHP 1b, with different mechanisms accounting for G alpha(s) deficiency. Clinical overlap between these two forms of PHP type 1 is likely due to the variable levels of G alpha(s) activity expressed in specific cell types.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)

Carlos R. Ferreira, Mary E. Hackbarth, Shira G. Ziegler, Kristen S. Pan, Mary S. Roberts, Douglas R. Rosing, Margaret S. Whelpley, Joy C. Bryant, Ellen F. Macnamara, Sisi Wang, Kerstin Mueller, Iris R. Hartley, Emily Y. Chew, Timothy E. Corden, Christina M. Jacobsen, Ingrid A. Holm, Frank Rutsch, Esra Dikoglu, Marcus Y. Chen, M. Zulf Mughal, Michael A. Levine, Rachel I. Gafni, William A. Gahl

Summary: Generalized arterial calcification of infancy (GACI) is usually caused by deficiency of ENPP1, and the natural history of GACI survivors has not been established. Out of 20 subjects, 16 presented with arterial calcifications, but only 5 had residual involvement at the time of evaluation.

GENETICS IN MEDICINE (2021)

Review Hematology

Parenteral iron therapy and phosphorus homeostasis: A review

Kamyar Kalantar-Zadeh, Tomas Ganz, Henry Trumbo, Melvin H. Seid, Lawrence T. Goodnough, Michael A. Levine

Summary: Phosphorus plays a crucial role in cellular and extracellular metabolism, and maintaining phosphorus homeostasis is vital. Intravenous iron formulations can lead to renal phosphate excretion and hypophosphatemia by increasing serum concentrations of intact fibroblast growth factor 23. Case studies provide insights into acute symptomatic and chronic hypophosphatemia, considering pre-existing conditions, medications, and intravenous iron's role. This review focuses on phosphorus homeostasis and hypophosphatemia, emphasizing the effects of iron deficiency and intravenous iron replacement.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Endocrinology & Metabolism

Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice

Carlos R. Ferreira, Dillon Kavanagh, Ralf Oheim, Kristin Zimmerman, Julian Stuerznickel, Xiaofeng Li, Paul Stabach, R. Luke Rettig, Logan Calderone, Colin MacKichan, Aaron Wang, Hunter A. Hutchinson, Tracy Nelson, Steven M. Tommasini, Simon von Kroge, Imke A. K. Fiedler, Ethan R. Lester, Gilbert W. Moeckel, Bjoern Busse, Thorsten Schinke, Thomas O. Carpenter, Michael A. Levine, Mark C. Horowitz, Demetrios T. Braddock

Summary: Mutations in ENPP1 can lead to early-onset osteoporosis and autosomal recessive hypophosphatemic rickets. Traditional therapy improved rickets but did not address low bone mineral density, highlighting the potential efficacy of ENPP1 enzyme replacement therapy.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Genetics & Heredity

A painting of the Christ Child with bowed legs: Rickets in the Renaissance

Colin P. Hawkes, Michael A. Levine

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2021)

Article Endocrinology & Metabolism

Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study

Nina Lenherr-Taube, Michelle Furman, Esther Assor, Yesmino Elia, Carol Collins, Kenneth Thummel, Michael A. Levine, Etienne Sochett

Summary: Idiopathic infantile hypercalcemia is a rare disorder with variable clinical features and the response to dietary calcium and vitamin D restriction in mild cases is not able to consistently normalize elevated 1,25(OH)2D concentrations or prevent worsening of renal calcification. Therapeutic options should focus on the defect in vitamin D metabolism.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome: A Family Report

Shira London, Michael A. Levine, Dong Li, Ronen Spiegel, Asaf Lebel, Rephael Halevy, Yardena Tenenbaum-Rakover

Summary: This study describes a child who presented with hypocalcemic seizure at the age of 2.3 years. Whole exome sequencing identified a known homozygous missense mutation in the KCNJ1 gene associated with type 2 BS. The findings expand the clinical spectrum of KCNJ1 mutations and highlight the role of WES in cases of hypocalcemia with suspected genetic causes.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Novel PTH Gene Mutations Causing Isolated Hypoparathyroidism

Colin P. Hawkes, Jamal M. Al Jubeh, Dong Li, Susan E. Tucker, Tara Rajiyah, Michael A. Levine

Summary: Parathyroid hormone (PTH) gene mutations are rare causes of hypoparathyroidism, which can lead to decreased or elevated levels of PTH. This study describes two novel mutations of the PTH gene, expanding our understanding of the molecular basis for familial isolated hypoparathyroidism (FIH).

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Review Endocrinology & Metabolism

An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture

Ashley J. Stoffers, David R. Weber, Michael A. Levine

Summary: This review provides the most up-to-date understanding of the pathogenesis, prevention, and treatment of vitamin D deficient rickets in children. Risk factors for developing this disorder include inadequate sunlight exposure, exclusive breast feeding without vitamin D supplementation, and inadequate intake of vitamin D, calcium, or phosphorus. It is critical to have a thorough understanding of the individual's vitamin D levels, which are influenced by both environmental and genetic factors, for the evaluation and treatment of children with rickets. Further research is needed to determine the ideal vitamin D status across diverse populations and the impact of vitamin D status on overall health.

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2022)

Article Genetics & Heredity

Mutation update: Variants of the ENPP1 gene in pathologic calcification, hypophosphatemic rickets, and cutaneous hypopigmentation with punctate keratoderma

Douglas Ralph, Michael A. Levine, Gabriele Richard, Michelle M. Morrow, Elizabeth K. Flynn, Jouni Uitto, Qiaoli Li

Summary: This article provides a comprehensive review of all the pathogenic variants, likely pathogenic variants, and variants of unknown significance in the ENPP1 gene associated with various genetic disorders. Missense variants are the most common. While there is no apparent genotype-phenotype correlation, specific variants are associated with Cole disease.

HUMAN MUTATION (2022)

Article Genetics & Heredity

ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification

Douglas Ralph, Yvonne Nitschke, Michael A. Levine, Matthew Caffet, Tamara Wurst, Amir Hossein Saeidian, Leila Youssefian, Hassan Vahidnezhad, Sharon F. Terry, Frank Rutsch, Jouni Uitto, Qiaoli Li

Summary: This study reveals that variants in the ENPP1 gene can cause both GACI and classic PXE, increasing the clinical and genetic diversity of hereditary ectopic calcification disorders. Additionally, the correlation between plasma PPi levels and the severity of vascular calcification is found to be limited in this study.

PLOS GENETICS (2022)

Review Endocrinology & Metabolism

Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review

Janice L. Pasieka, Kelly Wentworth, Caitlin T. Yeo, Serge Cremers, David Dempster, Seiji Fukumoto, Ravinder Goswami, Pascal Houillier, Michael A. Levine, Jesse D. Pasternak, Nancy D. Perrier, Antonio Sitges-Serra, Dolores M. Shoback

Summary: This article utilized a systematic review to investigate the etiologies and pathogenesis of hypoparathyroidism, with a particular focus on new knowledge about parathyroid gland viability and intraoperative parathyroid hormone monitoring. Non-surgical factors, especially genetic factors, play a significant role in hypoparathyroidism. Due to the widespread impact of PTH deficiency on multiple organ systems, the article provides a detailed review of skeletal, renal, neuromuscular, and ocular complications. The burden of illness on patients and their caregivers leads to reduced quality of life and increased social costs for this chronic endocrinopathy.

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

Review Endocrinology & Metabolism

One half-century of advances in the evaluation and management of disorders of bone and mineral metabolism in children and adolescents

Allen W. Root, Michael A. Levine

Summary: The past 50 years of research in pediatric bone and mineral metabolism have led to significant progress in understanding and characterizing disorders that affect the developing skeleton. Key findings include the identification of important proteins and receptors involved in calcium and phosphate metabolism, as well as the genetic causes for various bone and mineral disorders. These discoveries will likely lead to the development of innovative treatments in the next decade that will improve the lives of children with these disorders.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics

Amnon Zung, Galia Barash, Ehud Banne, Michael A. Levine

Summary: We report a novel heterozygous mutation in the CASR gene that causes autosomal dominant hypocalcemia type 1. The mutation increases the sensitivity of the CASR to extracellular calcium. Clinical features included seizures, reduced renal calcium reabsorption, and early lens opacity. Based on the comprehensive clinical data, we propose age-specific upper limit of serum calcium levels to balance the risk of seizures and hypercalciuria.

HORMONE RESEARCH IN PAEDIATRICS (2023)

Article Endocrinology & Metabolism

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism

Nelson B. Watts, John P. Bilezikian, Henry G. Bone, Bart L. Clarke, Douglas Denham, Michael A. Levine, Michael Mannstadt, Munro Peacock, Jeffrey G. Rothman, Tamara J. Vokes, Mark L. Warren, Shaoming Yin, Nicole Sherry, Dolores M. Shoback

Summary: This study evaluated the long-term safety and efficacy of recombinant human parathyroid hormone (1-84) (rhPTH(1-84)) treatment for chronic hypoparathyroidism. The results showed sustained improvements in biochemical parameters, a reduction in the percentage of patients with hypercalciuria, stable renal function, and decreased supplement requirements over 6 years of treatment with rhPTH(1-84). rhPTH(1-84) was well tolerated, and no new safety signals were identified.

JOURNAL OF THE ENDOCRINE SOCIETY (2023)

Article Biochemistry & Molecular Biology

Periodontal Disease, Local and Systemic Inflammation in Puerto Ricans with Type 2 Diabetes Mellitus

Oelisoa M. Andriankaja, Reuben Adatorwovor, Alpdogan Kantarci, Hatice Hasturk, Luciana Shaddox, Michael A. Levine

Summary: This study assessed the association between serum or gingival crevicular fluid endothelial and inflammatory mediators and chronic periodontal disease among Hispanic adults with type 2 diabetes. The findings showed that oral and systemic endothelial and inflammatory mediators are related to periodontal clinical parameters.

BIOMEDICINES (2023)

No Data Available